Directory Groups

Immunimed Inc.

ImmuniMed Inc. is an innovative, clinical-stage, Research & Development Biopharmaceutical Company. ImmuniMed Inc. develops oral antibody therapy using passive vaccination to treat and prevent gastro-enteric infections. Their technology is designed to utilize chicken eggs as bioreactors to manufacture specific polyclonal antibodies – a new class of biopharmaceuticals.

Back

Contact Info

T: 1 204 487 0974
Immunimed Inc. 6-62 Scurfield Blvd. Winnipeg R3Y 1M5 MB Canada
6-62 Scurfield Blvd.
Winnipeg R3Y 1M5 MB Canada
E: dr.pmaiti@neutratechglobal.com